We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
EWS-FLI1 target genes recovered from Ewing's sarcoma chromatin.
- Authors
Siligan, Christine; Ban, Jozef; Bachmaier, Radostina; Spahn, Laura; Kreppel, Michael; Schaefer, Karl-Ludwig; Poremba, Christopher; Aryee, Dave N T; Kovar, Heinrich
- Abstract
In all, 85% of Ewing's sarcoma family tumors (ESFT), a neoplasm of unknown histogenesis, express EWS-FLI1 transcription factor gene fusions. To characterize direct target genes avoiding artificial model systems, we cloned genomic DNA from ESFT chromatin precipitating with EWS-FLI1. We now present a comprehensive list of 99 putative transcription factor targets identified, for the first time, by a hypothesis-free approach based on physical interaction. Gene-derived chromatin fragments co-precipitating with EWS-FLI1 were nonrandomly distributed over the human genome and localized predominantly to the upstream region and the first two introns of the genes. At least 20% of putative direct EWS-FLI1 targets were neural genes. One-third of genes recovered showed a significant ESFT-specific expression pattern and were found to be altered upon RNAi-mediated knockdown of EWS-FLI1. Among them, MK-STYX, encoding a MAP kinase phosphatase-like protein, was consistently expressed in ESFT. EWS-FLI1 was found to drive MK-STYX expression by binding to a single ETS binding motif within the first gene intron. MK-STYX serves as precedence for successful recovery of direct EWS-FLI1 targets from the authentic ESFT cellular context, the most relevant system to study oncogenic mechanisms for the discovery of new therapeutic targets in this disease.
- Publication
Oncogene, 2005, Vol 24, Issue 15, p2512
- ISSN
0950-9232
- Publication type
Journal Article
- DOI
10.1038/sj.onc.1208455